Tag:

3 Fatal Cases

3 Fatal Cases and New Challenges for the Field: What Lies Ahead for CAR T-Cell Therapy in the Treatment of Autoimmune Diseases

Three patient deaths have forced a pause in several clinical trials testing CAR T-cell therapies for autoimmune and neurological diseases, raising urgent questions about...